603
Participants
Start Date
May 30, 2019
Primary Completion Date
February 11, 2025
Study Completion Date
February 17, 2025
High-dose dual therapy (rabeprazole, amoxicillin)
High-dose dual therapy (rabeprazole 20 mg qid + amoxicillin 750 mg qid, for 14 days)
Bismuth High-dose dual therapy (rabeprazole, amoxicillin, tripotassium dicitrate bismuthate)
Bismuth-High-dose dual therapy (rabeprazole 20 mg qid + amoxicillin 750 mg qid + tripotassium dicitrate bismuthate 300 mg qid, for 14 days)
Amoxicillin-Metronidazole Bismuth quadruple therapy
Amoxicillin-Metronidazole Bismuth quadruple therapy (rabeprazole 20 mg bid + tripotassium dicitrate bismuthate 600 mg bid + amoxicillin 1000 mg bid + metronidazole 500 mg tid, for 14 days)
National Taiwan University Hospital, Taipei
Ministry of Science and Technology, Taiwan
OTHER_GOV
National Taiwan University Hospital
OTHER